Harnessing Tolypothrix sp. A-8 for biogenic synthesis of silver oxide nanoparticles (AgONPs) for multifunctional biomedical applications Authors: Muhammad Kaleem, Lubna Anjum Minhas, Amber Jabeen, Muhammad Abdullah, Ghulam Mustafa Bajwa, Hafiz Muhammad Umer Farooqi, Dovran Shamamedov, Abdul Samad Mumtaz Published: 2026 ABSTRACT Green nanotechnology leverages biological systems for the sustainable synthesis of nanomaterials, offering an eco-friendly alternative to conventional methods. In this study, we report the phyco-synthesis of silver oxide nanoparticles (AgONPs) using an aqueous extract of Tolypothrix sp. A-8, a cyanobacterium rich in bioactive metabolites that serve as both reducing and capping agents. Synthesis was optimized by controlling key physicochemical parameters (reaction time, precursor concentration, temperature, and pH) to maximize yield. The resulting nanoparticles were comprehensively characterized using X-Ray Diffraction, Ultraviolet Visible Spectroscopy (UV), Fourier Transform Infrared Spectroscopy, Dynamic Light Scattering, Scanning Electron Microscopy, and Energy-Dispersive X-ray Spectroscopy. The AgONPs demonstrated significant anti-leishmanial activity, with IC50 values of 10.43 µg/mL against promastigotes and 32.43 µg/mL against amastigotes of Leishmania tropica, and an LD50 of 45 µg/mL against Artemia salina. In anticancer assays against HCT-116 colorectal carcinoma cells, the nanoparticles induced cytotoxicity, with an IC50 of approximately 8512 µg/mL. They also exhibited notable antioxidant potential, with total antioxidant capacity and total reducing power reaching 58.4% and 51.4%, respectively, at 300 µg/mL. The AgONPs were highly biocompatible, showing non-hemolytic effects at concentrations up to 200 µg/mL (3.2% hemolysis) and an IC50 of 918.2 µg/mL against human macrophages, confirming their non-toxic nature. Anti-inflammatory activity was confirmed via human red blood cell membrane stabilization, with a 62.8% reduction in hemolysis. Furthermore, the nanoparticles demonstrated dose-dependent anti-diabetic potential, achieving 23.3% glucose scavenging at 900 µg/mL. Antimicrobial assays revealed potent activity, with minimum inhibitory concentrations of 50 µg/mL against Botrytis cinerea, Staphylococcus aureus, and coagulase-negative Staphylococcus, while Bacillus subtilis was the least susceptible bacterial strain (MIC: 150 µg/mL). This study pioneers Tolypothrix sp. A-8 as a scalable biofactory for the sustainable production of multifunctional AgONPs. With their potent, quantitative bioactivities and excellent biocompatibility, these nanomaterials hold significant promise for next-generation nanotherapeutics, including applications in wound healing, targeted drug delivery, and the management of leishmaniasis, cancer, inflammation, and diabetes.Supplementary InformationThe online version contains supplementary material available at 10.1186/s11671-026-04671-x. Introduction Nanotechnology is a dynamic and widely recognized field of research focused on fabricating nanoparticles (NPs) with diverse shapes and sizes [1–3]. Metal-based NPs, in particular, are extensively utilized across numerous industries—including pharmacology [4], optical electronics [5], plasmonics [6], sensors [7], water purification [8], and catalysis [9], owing to their exceptional chemical and physical properties. Successful chemical synthesis has been reported for various metal NPs, including silver (Ag) [10, 11], gold (Au) [12], zinc (Zn) [13, 14], copper (Cu), titanium (Ti) and tellurium [15, 16], cadmium (Cd) [17, 18], iron (Fe) [19, 20], and selenium [21]. Among these, silver oxide nanoparticles (AgONPs) possess unique characteristics that render them highly suitable for diverse biological applications, including biosensors, antimicrobial agents, composite fibers, cosmetics, cryogenic superconductors, pharmaceuticals, and dental materials [22]. However, the limitations of conventional chemical and physical synthesis methods—such as environmental toxicity, high cost, and energy intensity—have driven growing interest in green chemistry approaches (Fig. 1) [23, 24]. Biological synthesis offers distinct advantages, including enhanced stability, solubility, yield, cost-effectiveness, and eco-friendliness [25].Fig. 1a Various methods of AgONPs synthesis b the illustration depicts the step-by-step process of synthesis of AgONPs utilizing Tolypothrix sp. A-8 as a biological mediator. c morphological features of Tolypothrix sp. A-8 d visual observation of Tolypothrix sp. A-8 derived AgONPs a Various methods of AgONPs synthesis b the illustration depicts the step-by-step process of synthesis of AgONPs utilizing Tolypothrix sp. A-8 as a biological mediator. c morphological features of Tolypothrix sp. A-8 d visual observation of Tolypothrix sp. A-8 derived AgONPs Natural products have historically served as valuable sources of safe and effective medications [26] with broad pharmacological actions and minimal side effects [27–29]. Over the past five decades, numerous natural compounds—such as paclitaxel, ginsenoside Rg3, indirubin, and artemisinin—have demonstrated significant therapeutic efficacy [30]. This has prompted exploration of various organisms for biogenic AgONP synthesis, including plant [31–33], bacteria [34], fungi [35], yeast [36], and algae [14, 37]. Algae have emerged as particularly promising model organisms for AgONP synthesis due to their rapid growth, cost-effectiveness, and high biomass productivity. Several algal species have been successfully employed for AgNO3 reduction and AgONP production, including Gelidium corneum [38], Spyridia flamentosa [38], Sargassum wightii [39], Lobophora variegata [40], Ulva armoricana [41], and Sargassum muticum [42], Nodularia haraviana [11], Calothrix elenkinii [43], Spirulina platensis and Nostoc linckia [44], Phormidium ambiguum and Desertifilum tharense [45], Oscillatoria and Spirulina [46], Pseudanabaena/Limnothrix sp [47], and Oscillatoria princep [48]. The bioactive compounds present in algae—including carotenoids, sterols, oligopeptides, and fatty acids—contribute to both the reduction process and the diverse biological applications of the resulting nanoparticles [41]. The present study investigates, for the first time, the green synthesis of AgONPs using the cyanobacterial extract of Tolypothrix sp. A-8, followed by comprehensive physicochemical characterization using X-Ray Diffraction (XRD), Ultraviolet Visible Spectroscopy (UV), Fourier Transform Infrared Spectroscopy (FTIR), Dynamic Light Scattering (DSL), Scanning Electron Microscopy (SEM), and Energy-Dispersive X-ray Spectroscopy (EDX). We systematically evaluated the impact of synthesis parameters (AgNO3 concentration, temperature, pH, and reaction time) on nanoparticle stability and yield. The biomedical potential of the synthesized AgONPs was assessed through multiple in vitro assays, including antimicrobial, antioxidant, anti-leishmanial, antineoplastic, anti-inflammatory, anti-diabetic, and protein kinase inhibition activities, alongside cytotoxicity and biocompatibility evaluations against human erythrocytes and macrophages. This comprehensive investigation aims to harness the synergistic potential of natural products and nanotechnology, paving the way for sustainable and innovative nature-inspired nanomedicines with practical therapeutic applications. Materials and methods Chemicals All chemicals used in this study were of analytical grade and used without further purification. Silver nitrate (AgNO3, ≥ 99.8% purity) was purchased from Sigma-Aldrich (USA). Ferric chloride hexahydrate (FeCl3·6H2O, ≥ 99.0% purity) and sodium hydroxide (NaOH, ≥ 98.0% purity) were obtained from Merck (Germany). Optimum culture conditions for cyanobacterial strain Tolypothrix sp. A-8 was cultivated in sterile BG-11 medium (composition per liter: NaNO3 1.5 g, K2HPO4 0.04 g, MgSO4·7H2O 0.075 g, CaCl2·2H2O 0.036 g, citric acid 0.006 g, ferric ammonium citrate 0.006 g, EDTA 0.001 g, Na2CO3 0.02 g, and 1 mL trace metal mix) using the flask-shake method at 28 ± 2 °C under continuous illumination (50 µmol photons m⁻2 s⁻1) with shaking at 120 rpm [49, 50]. Growth was monitored by optical density at 680 nm, and cells were harvested during the late exponential phase (Day 14–16, OD680 1.2–1.5) by centrifugation at 10,000 rpm for 15 min at 4 °C. The pellet was washed three times with sterile distilled water, dried at 55% humidity for 24 h at room temperature, and ground into a fine powder. To ensure culture purity, routine microscopic examination and streak plating on nutrient agar was done. To prevent mutation, cultures were subcultured maximum five times from frozen stocks cryopreserved in 10% glycerol at − 80 °C. For extract preparation, 1.6 g of dried cyanobacterial powder was stirred in 100 mL sterile deionized water at 50 °C for 3 h, filtered through Whatman No. 1 filter paper followed by 0.45 µm membrane filtration, and stored at 4 °C. Extract sterility was confirmed by plating on nutrient agar, and BG-11 agar with no colony formation. Bioinspired synthesis of Tolypothrix sp. A-8 derived AgONPs The synthesis was initiated by combining 50 mL of filtered Tolypothrix sp. A-8 extract with 3 g of silver nitrate [11]. The mixture was heated at 70 °C for 2 h on a hot plate with constant stirring to accelerate the reaction (final pH 9.73). A color transition from dark brown to light brown provided initial visual confirmation of AgONP synthesis. The reaction mixture was subsequently centrifuged at 3000 rpm for 30 min (Fig. 1b). The resulting pellet was washed with sterile water to remove impurities, then dried at 75 °C for 2 h. The dried sample was calcined at 400 °C for 2 h in an open-air furnace [19]. The calcined nanoparticles were stored in a cool, dark, and dry environment for subsequent analyses. Environmental factors affecting AgONPs stability The aqueous extract of Tolypothrix sp. A-8 cyanobacteria were used to fabricate AgONPs. To determine the stability of the AgONPs, several factors were examined, including pH, temperature, time, and AgNO3 concentration [51]. After 6–12 h of dark incubation at room temperature, AgONPs were subjected to a spectrophotometric examination to determine the favorable conditions for reducing silver ions and the subsequent formation of silver nanoparticles. AgNO3 was employed at several doses (0.1, 0.2, 0.3, 0.4, and 0.5 mM) to evaluate its effects on AgONPs synthesis. To find the best AgNO3 concentration, the absorbance of the nanoparticles was assessed using a UV–visible spectrophotometer. After synthesizing NPs, each reaction tube was maintained at that temperature for 20 min. The synthesis was carried out at a variety of temperatures, including 20 °C, 30 °C, 40 °C, 50 °C, and 60 °C. The reaction solution containing AgONPs was adjusted at different pH (2, 4, 6, 8, and 10) using 0.1 mol/l NaOH to check the stability of AgONPs. By observing the behavior of AgONPs under varying pH conditions, we aimed to understand how pH influences their stability and properties. Spectroscopic characterizations of AgONPs The synthesis of AgONPs was assessed by observing the color change. The formation of AgONPs was monitored using a UV vis spectrophotometer ((UV-4000 spectrophotometer, Berlin, Germany) with a resolution of 1nm. It covered a wavelength of 800–200nm. The color change in the mixture served as an indication of the synthesis of AgONPs. FTIR (Thermo Scientific Fisher Nicolete IS10, Waltham, MA, USA) analysis was used to identify biomolecules involved in synthesizing AgONPs. A powdered AgONPs sample weighing 2 mg was combined with 20 mg of KBr and compressed into a pellet. The analysis was taken between the wavelength of 500–4000 cm−1. The sample in powdered form was carefully placed onto a glass slide and then analyzed using a Bruker D8 Advanced Powder Diffractometer through XRD (PANalytical, Almelo, The Netherlands, Europe) analysis. The examination contained the values between 10° and 80°. The obtained data was further processed using X’pert Highscore and Origin lab software. For SEM analysis, a small drop of NPs suspension was applied onto an SEM grid coated with Aluminum. Subsequently, the sample was analyzed using a SEM (JSM5910 JEOL, Tokyo, Japan) instrument coupled with an EDX (Malvern Zetasizer Nano, Tokyo, Japan). ZP, PDI (Polydispersity index), and hydrodynamic size distribution were assessed using a Zeta size instrument (Malvern Zetasizer Nano). For the analysis, 200 µg of AgONPs were dissolved in deionized water (2 mL) (Milli-Q) using a bath sonicator for 40 min. The suspension was then moved into a collapsible capillary cell to analyze conductivity and Zeta potential. Tolypothrix sp. A-8 Driven AgONPs for pharmaceutical applications Toxicity evolution of AgONPs derived from Tolypothrix sp. A-8 Cytotoxicity of biogenic AgONPs was evaluated using a brine shrimp (Artemia salina) bioassay [17]. Artemia salina eggs (S.K. Artemia Cysts, USA) were hatched in seawater (3.8 g/L salinity) under light at 30 °C for 24–48 h. Mature nauplii were collected using Pasteur pipettes and transferred to glass vials containing AgONPs at concentrations ranging from 6.25 to 300 µg/mL. Vincristine served as the positive control, while DMSO in seawater served as the negative control. After 24 h incubation, dead shrimp were counted, and the IC50 value was calculated using GraphPad software.1\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\mathrm{P}\mathrm{e}\mathrm{r}\mathrm{c}\mathrm{e}\mathrm{n}\mathrm{t}\mathrm{a}\mathrm{g}\mathrm{e}\, \mathrm{I}\mathrm{n}\mathrm{h}\mathrm{i}\mathrm{b}\mathrm{i}\mathrm{t}\mathrm{i}\mathrm{o}\mathrm{n}=\left[\left\{1-\frac{\mathrm{s}\mathrm{a}\mathrm{m}\mathrm{p}\mathrm{l}\mathrm{e}}{\mathrm{c}\mathrm{o}\mathrm{n}\mathrm{t}\mathrm{r}\mathrm{o}\mathrm{l}}\right\}\right]\times 100$$\end{document} The cytotoxic potential of AgONPs was further assessed against Leishmania tropica promastigotes and amastigotes [52]. Parasites were cultured in MI99 medium supplemented with 10% FBS. Cells were treated with AgONPs (6.25–300 µg/mL) in 96-well plates and incubated at 24 °C for 72 h in a CO2 incubator. Amphotericin-B served as the positive control, and DMSO as the negative control. Absorbance was measured at 540 nm, and inhibition was calculated using Eq. (2).2\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\mathrm{P}\mathrm{e}\mathrm{r}\mathrm{c}\mathrm{e}\mathrm{n}\mathrm{t}\mathrm{a}\mathrm{g}\mathrm{e}\, \mathrm{I}\mathrm{n}\mathrm{h}\mathrm{i}\mathrm{b}\mathrm{i}\mathrm{t}\mathrm{i}\mathrm{o}\mathrm{n}=\left[\left\{1-\frac{\mathrm{A}\mathrm{b}\mathrm{s}\mathrm{o}\mathrm{r}\mathrm{b}\mathrm{a}\mathrm{n}\mathrm{c}\mathrm{e}\, \mathrm{o}\mathrm{f}\, \mathrm{s}\mathrm{a}\mathrm{m}\mathrm{p}\mathrm{l}\mathrm{e}}{\mathrm{A}\mathrm{b}\mathrm{s}\mathrm{o}\mathrm{r}\mathrm{b}\mathrm{a}\mathrm{n}\mathrm{c}\mathrm{e}\, \mathrm{o}\mathrm{f}\, \mathrm{c}\mathrm{o}\mathrm{n}\mathrm{t}\mathrm{r}\mathrm{o}\mathrm{l}}\right\}\right]\times 100$$\end{document} Anticancer assessment The HCT-116 human colorectal cancer cell line (ATCC CCL-247) was provided by the H.E.J research institute of Chemistry, University of Karachi, Pakistan for research application. The cells were grown as monolayers in McCoy’s 5A medium supplemented with 10% fetal bovine serum (FBS) (Gibco) and 1% antibiotics (penicillin and streptomycin) to test the in vitro efficacy against tumors. Cell subculturing was carried out every two weeks under incubation settings of 37 °C, 5% CO2, and 100% relative humidity. The procedure initially described in [53, 54] was followed with minor modifications described in [55] for optimization. The absorbance was measured through a spectrophotometer at 50 nm after 24h. Growth inhibition was then estimated using the following method:3\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$ {\mathrm{Cell}}\;{\mathrm{viability}} = {\mathrm{OD}}\;\left( {{\mathrm{control}}\;{\mathrm{well}}} \right) - {\mathrm{OD}}\;\left( {{\mathrm{treated}}\;{\mathrm{well}}} \right) \times 100 $$\end{document} Free radical scavenging (FRS) potential of AgONPs The antioxidant potential of AgONPs was evaluated using the DPPH assay [56]. The working solution was prepared by dissolving 2.4 mg DPPH in 25 mL methanol. AgONPs at various concentrations (6.25–300 µg/mL) were mixed with the reagent solution (20 µL sample + 180 µL reagent). Ascorbic acid served as the positive control, and DMSO as the negative control. The reaction mixtures were incubated in darkness for 2 h, and absorbance was measured at 517 nm. Radical scavenging activity was calculated using Eq. (4). Total antioxidant capacity was determined using the phosphomolybdenum method [57]. Sample absorbance was measured at 695 nm. Results were expressed as ascorbic acid equivalents (AAE) per milligram of sample. Ascorbic acid and DMSO served as positive and negative controls, respectively. The reducing power of AgONPs was assessed using the potassium ferricyanide method [14]. Absorbance was measured at 630 nm, and results were expressed as ascorbic acid equivalents (AAE/mg). Ascorbic acid served as the positive control, and DMSO as the negative control. This assay evaluated the electron-donating capacity of AgONPs.4\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$ {\mathrm{Percentage}}\;{\mathrm{DPPH}}\;{\mathrm{Scavanging}} = \left[ {\left\{ {1 - \frac{{{\mathrm{ABs}}.\;{\mathrm{sample}}}}{{{\mathrm{ABs}}.\;{\mathrm{control}}}}} \right\}} \right] \times 100 $$\end{document} Evaluation of biocompatibility against human erythrocytes The biocompatibility of biogenic AgONPs was investigated using human red blood cells (RBCs) [14]. Fresh human blood (2 mL) was obtained from the Quaid-i-Azam University Medical Centre (provided by first author) with institutional approval. 1 ml of freshly obtained RBCs were put in a falcon tube and treated with ethylene diamine tetra acetic acid (EDTA) to avoid blood coagulation. The falcon tube was centrifuged at 12,000 rpm for 10 min to separate the RBCs. 200 µL of RBCs were mixed with phosphate-buffered saline (PBS) at a pH of 7.2 to create the reaction mixture. Different concentrations of AgONPs ranging from 6.25 to 300 µg/mL were added to 100 µL of the RBCs solution, and the resultant mixture was then incubated at 35 °C for 1h. After the centrifugation of the mixture at 12,000 rpm, the supernatant was transferred into a 96-well plate, and the quantity of hemoglobin was measured at 540 nm. The findings were calculated using Eq. (5) and were reported as the percentage of hemolysis caused by AgONPs.5\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\mathrm{P}\mathrm{e}\mathrm{r}\mathrm{c}\mathrm{e}\mathrm{n}\mathrm{t}\mathrm{a}\mathrm{g}\mathrm{e}\, \mathrm{h}\mathrm{e}\mathrm{m}\mathrm{o}\mathrm{l}\mathrm{y}\mathrm{s}\mathrm{i}\mathrm{s} =\left[\frac{\mathrm{S}\mathrm{a}\mathrm{m}\mathrm{p}\mathrm{l}\mathrm{e}\, \mathrm{a}\mathrm{b}\mathrm{s}\mathrm{o}\mathrm{r}\mathrm{b}\mathrm{a}\mathrm{n}\mathrm{c}\mathrm{e}-\mathrm{N}\mathrm{e}\mathrm{g}. \mathrm{c}\mathrm{o}\mathrm{n}\mathrm{t}\mathrm{r}\mathrm{o}\mathrm{l}\, \mathrm{a}\mathrm{b}\mathrm{s}\mathrm{o}\mathrm{r}\mathrm{b}\mathrm{a}\mathrm{n}\mathrm{c}\mathrm{e} }{\mathrm{P}\mathrm{o}\mathrm{s}. \mathrm{c}\mathrm{o}\mathrm{n}\mathrm{t}\mathrm{r}\mathrm{o}\mathrm{l}\, \mathrm{a}\mathrm{b}\mathrm{s}\mathrm{o}\mathrm{r}\mathrm{b}\mathrm{a}\mathrm{n}\mathrm{c}\mathrm{e}-\mathrm{N}\mathrm{e}\mathrm{g}. \mathrm{c}\mathrm{o}\mathrm{n}\mathrm{t}\mathrm{r}\mathrm{o}\mathrm{l}\, \mathrm{a}\mathrm{b}\mathrm{s}\mathrm{o}\mathrm{r}\mathrm{b}\mathrm{a}\mathrm{n}\mathrm{c}\mathrm{e} }\right]\times 100$$\end{document} The biogenic AgONPs’ biocompatibility nature was also investigated using human macrophages (HMs) [58]. HMs were cultured in RPMI media with 25% mM herpes, 10% FBS, and antibiotics. Additionally, the HMs were grown on 96-well plates and subjected to a 5% carbon dioxide atmosphere for 24 h to enhance cell adhesion. The HMs were treated to various concentrations (6.25–300 µg/mL) of biogenic AgONPs. Equation (6) was used to calculate the % inhibition:6\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\mathrm{P}\mathrm{e}\mathrm{r}\mathrm{c}\mathrm{e}\mathrm{n}\mathrm{t}\mathrm{a}\mathrm{g}\mathrm{e}\, \mathrm{I}\mathrm{n}\mathrm{h}\mathrm{i}\mathrm{b}\mathrm{i}\mathrm{t}\mathrm{i}\mathrm{o}\mathrm{n}=\left[\left\{1-\frac{ \mathrm{A}\mathrm{b}\mathrm{s}\mathrm{o}\mathrm{r}\mathrm{b}\mathrm{a}\mathrm{n}\mathrm{c}\mathrm{e}\, \mathrm{o}\mathrm{f}\, \mathrm{s}\mathrm{a}\mathrm{m}\mathrm{p}\mathrm{l}\mathrm{e}}{\mathrm{A}\mathrm{b}\mathrm{s}\mathrm{o}\mathrm{r}\mathrm{b}\mathrm{a}\mathrm{n}\mathrm{c}\mathrm{e}\, \mathrm{o}\mathrm{f}\, \mathrm{c}\mathrm{o}\mathrm{n}\mathrm{t}\mathrm{r}\mathrm{o}\mathrm{l}}\right\}\right]\times 100$$\end{document} Assessment of anti-inflammatory response AgONPs anti-inflammatory response was assessed in vitro through membrane stabilization techniques for human RBCs. Blood samples were taken from healthy individuals and mixed with the same volume of sterile Alsevers solution. An RBC pellet was obtained by centrifuging the mixture for 15 min at 3000 rpm. The pellet was washed thrice with an isosaline solution and a 10% HRBC suspension. Tolypothrix sp. A-8 mediated AgONPs were mixed with 1 mL of phosphate buffer, 2 ml of hyposaline, and 1.5 mL of RBCs solution. After that, the mixture was incubated at 37 °C for 30 min. The reaction mixture was centrifuged for 10 min at 3000 rpm after incubation. Using spectrophotometry, the absorbance of the supernatant was determined at 560 nm. Diclofenac served as the standard drug [59]. The percentage of hemolysis was computed by reducing the proportion of hemolysis in the control group to 100% [59, 60]. The rate of protection/ percentage inhibition of hemolysis was evaluated using Eq. 7.7\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\mathrm{P}\mathrm{e}\mathrm{r}\mathrm{c}\mathrm{e}\mathrm{n}\mathrm{t}\mathrm{a}\mathrm{g}\mathrm{e}\, \mathrm{o}\mathrm{f}\, \mathrm{p}\mathrm{r}\mathrm{o}\mathrm{t}\mathrm{e}\mathrm{c}\mathrm{t}\mathrm{i}\mathrm{o}\mathrm{n}=\left[\left\{100-\frac{\mathrm{A}\mathrm{b}\mathrm{s}\mathrm{o}\mathrm{r}\mathrm{b}\mathrm{a}\mathrm{n}\mathrm{c}\mathrm{e}\, \mathrm{o}\mathrm{f}\, \mathrm{s}\mathrm{a}\mathrm{m}\mathrm{p}\mathrm{l}\mathrm{e}}{\mathrm{A}\mathrm{b}\mathrm{s}\mathrm{o}\mathrm{r}\mathrm{b}\mathrm{a}\mathrm{n}\mathrm{c}\mathrm{e}\, \mathrm{o}\mathrm{f}\, \mathrm{c}\mathrm{o}\mathrm{n}\mathrm{t}\mathrm{r}\mathrm{o}\mathrm{l}}\right\}\right]\times 100$$\end{document} Anti-diabetic assay Anti-diabetic activity for AgONPs was analyzed using the Alpha-amylase (AA) inhibition assay [61]. Initially, 25 µL of AA, 10 µL of AgONPs, 15 µL of FBS, and 40 µL of starch solution were combined to formulate the reaction mixture. The reaction mixture was then added to a solution of HCl (90 mL) and iodine (20 mL). The resulting mixture was then given a 30 min incubation time at 50 °C. Ascorbose was utilized as the positive control, while distilled water was used as the negative control. The percentage activity was measured by using Eq. 8.8\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\mathrm{P}\mathrm{e}\mathrm{r}\mathrm{c}\mathrm{e}\mathrm{n}\mathrm{t}\mathrm{a}\mathrm{g}\mathrm{e}\, \mathrm{i}\mathrm{n}\mathrm{h}\mathrm{i}\mathrm{b}\mathrm{i}\mathrm{t}\mathrm{i}\mathrm{o}\mathrm{n} =[\frac{\mathrm{S}\mathrm{a}\mathrm{m}\mathrm{p}\mathrm{l}\mathrm{e}\, \mathrm{a}\mathrm{b}\mathrm{s}\mathrm{o}\mathrm{r}\mathrm{b}\mathrm{a}\mathrm{n}\mathrm{c}\mathrm{e}-\mathrm{N}\mathrm{e}\mathrm{g}. \mathrm{c}\mathrm{o}\mathrm{n}\mathrm{t}\mathrm{r}\mathrm{o}\mathrm{l}\, \mathrm{a}\mathrm{b}\mathrm{s}\mathrm{o}\mathrm{r}\mathrm{b}\mathrm{a}\mathrm{n}\mathrm{c}\mathrm{e} }{\mathrm{P}\mathrm{o}\mathrm{s}. \mathrm{c}\mathrm{o}\mathrm{n}\mathrm{t}\mathrm{r}\mathrm{o}\mathrm{l}\, \mathrm{a}\mathrm{b}\mathrm{s}\mathrm{o}\mathrm{r}\mathrm{b}\mathrm{a}\mathrm{n}\mathrm{c}\mathrm{e}-\mathrm{N}\mathrm{e}\mathrm{g}.\mathrm{c}\mathrm{o}\mathrm{n}\mathrm{t}\mathrm{r}\mathrm{o}\mathrm{l}\, \mathrm{a}\mathrm{b}\mathrm{s}\mathrm{o}\mathrm{r}\mathrm{b}\mathrm{a}\mathrm{n}\mathrm{c}\mathrm{e} }]\times 100$$\end{document} Protein kinase inhibitory potential The potential of AgONPs was investigated using Streptomyces 85E strain, following a previously established method outlined by Minhas et al. [19]. The protein kinase (PK) inhibitory activity was performed under sterile conditions, employing a minimal SP4 medium to create lawn Streptomyces. Circular filter discs containing 10 µL of AgONPs were placed on the Streptomyces lawn in the Petri dishes to assess the inhibition of PK. DMSO was used as the negative control for comparison, whereas Surfactin was used as the positive control. For 72 h, the Streptomyces 85E strain was grown at 30 °C to support its growth. After 24 h, discrete clear zones suggested that spore formation and mycelia adhesion had been inhibited. The zone of inhibition (ZOI) resulting from the PK inhibitory activity was measured using a specific Eq. 10.10\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\mathrm{P}\mathrm{e}\mathrm{r}\mathrm{c}\mathrm{e}\mathrm{n}\mathrm{t}\mathrm{a}\mathrm{g}\mathrm{e}\, \mathrm{i}\mathrm{n}\mathrm{h}\mathrm{i}\mathrm{b}\mathrm{i}\mathrm{t}\mathrm{i}\mathrm{o}\mathrm{n} =\left[\frac{\mathrm{S}\mathrm{a}\mathrm{m}\mathrm{p}\mathrm{l}\mathrm{e}\, \mathrm{a}\mathrm{b}\mathrm{s}\mathrm{o}\mathrm{r}\mathrm{b}\mathrm{a}\mathrm{n}\mathrm{c}\mathrm{e}-\mathrm{N}\mathrm{e}\mathrm{g}. \mathrm{c}\mathrm{o}\mathrm{n}\mathrm{t}\mathrm{r}\mathrm{o}\mathrm{l}\, \mathrm{a}\mathrm{b}\mathrm{s}\mathrm{o}\mathrm{r}\mathrm{b}\mathrm{a}\mathrm{n}\mathrm{c}\mathrm{e} }{\mathrm{P}\mathrm{o}\mathrm{s}. \mathrm{c}\mathrm{o}\mathrm{n}\mathrm{t}\mathrm{r}\mathrm{o}\mathrm{l}\, \mathrm{a}\mathrm{b}\mathrm{s}\mathrm{o}\mathrm{r}\mathrm{b}\mathrm{a}\mathrm{n}\mathrm{c}\mathrm{e}-\mathrm{N}\mathrm{e}\mathrm{g}. \mathrm{c}\mathrm{o}\mathrm{n}\mathrm{t}\mathrm{r}\mathrm{o}\mathrm{l}\, \mathrm{a}\mathrm{b}\mathrm{s}\mathrm{o}\mathrm{r}\mathrm{b}\mathrm{a}\mathrm{n}\mathrm{c}\mathrm{e} }\right]\times 100$$\end{document} Antimicrobial activity of AgONPs The antifungal (AF) activity of AgONPs was investigated using the food poisoning method [62]. The preserved fungus strains were cultured in PDA media at 26 °C for 72 h. PDA medium was mixed with AgONPs at different concentrations (200–50 µg/mL) for this study. Using a cork borer, a 4 mm-diameter fungal inoculum disc was inserted into the middle of each PDA plate. As a positive control, PDA plates devoid of nanoparticles were used. The antibacterial (AB) assay of the AgONPs was investigated using the disc diffusion method [56]. Microbial strains obtained from Plant–Microbe Interaction laboratory at Quaid I Azam University, Islamabad and are routinely cultured and used for antimicrobial assays. Fresh bacterial colonies were inoculated into nutrient broth medium and incubated at 37 °C for 16–24 h to achieve log phase growth, with turbidity adjusted to 0.5 McFarland (~ 1 × 108 CFU/mL) using sterile saline. To measure the AgONPs’ antibacterial (AB) efficacy, a BS culture was spread out on an agar medium and given 5 min to air dry. Next, filter discs with different concentrations of AgONPs (50–200 µg/mL) were added to the agar surface. A ZOI developed on the plates after 24 h at 37 °C in the incubator. DMSO (5%) was used to establish the baseline as the negative control and kanamycin-A as the positive control. Insecticidal impact assessment Effect of biosynthesized AgONPs at a concentration of (2038.5 µg /cm2 /3mL of ethanol) on several insects, including Sitophilus oryzea, Rhyzopertha dominica, and Tribolium castaneum [63]. The concentrations were applied to petri dishes covered with filter paper. Ten test insects were added to each dish after 24 h. After that, the plates were incubated for 24 h at 27 °C and 50% relative humidity in a growth chamber. Test insects and standard pesticide permethrin at 239.5µg/cm2 were utilized as the positive control, while test insects and methanol were employed as the negative control. The following formula (11) was used to calculate the percentage mortality:11\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\mathrm{G}\mathrm{r}\mathrm{o}\mathrm{w}\mathrm{t}\mathrm{h}\, \mathrm{r}\mathrm{e}\mathrm{g}\mathrm{u}\mathrm{l}\mathrm{a}\mathrm{t}\mathrm{i}\mathrm{o}\mathrm{n} (\mathrm{\%}) =\left[\frac{\mathrm{N}\mathrm{u}\mathrm{m}\mathrm{b}\mathrm{e}\mathrm{r}\, \mathrm{o}\mathrm{f}\, \mathrm{i}\mathrm{n}\mathrm{s}\mathrm{e}\mathrm{c}\mathrm{t}\mathrm{s}\, \mathrm{a}\mathrm{l}\mathrm{i}\mathrm{v}\mathrm{e}\, \mathrm{i}\mathrm{n}\, \mathrm{c}\mathrm{o}\mathrm{n}\mathrm{t}\mathrm{r}\mathrm{o}\mathrm{l} }{\mathrm{N}\mathrm{u}\mathrm{m}\mathrm{b}\mathrm{e}\mathrm{r}\, \mathrm{o}\mathrm{f}\, \mathrm{i}\mathrm{n}\mathrm{s}\mathrm{e}\mathrm{c}\mathrm{t}\mathrm{s}\, \mathrm{a}\mathrm{l}\mathrm{i}\mathrm{v}\mathrm{e}\, \mathrm{i}\mathrm{n}\, \mathrm{t}\mathrm{e}\mathrm{s}\mathrm{t} }\right]\times 100$$\end{document} Statistical analysis The results of the DPPH radical scavenging activity, total antioxidant activity, cytotoxicity, antimicrobial activity, enzyme inhibition, anti-inflammatory, insecticidal, and biocompatibility tests are presented as mean values ± standard deviations obtained from three independent replicates per sample. Statistical analysis was conducted using software packages such as Microsoft Excel, Origin Lab, and GraphPad Prism. For comparisons among multiple groups, a one-way analysis of variance (ANOVA) was performed, and statistical significance was determined based on the ANOVA F-test. Results and discussion Optimal growth parameters and Identification of Tolypothrix sp. A-8 A light microscope was used to evaluate the cyanobacterial strain’s isolation, purity, and morphology. The selected strain has a filamentous structure with lateral and intercalary heterocysts. The strain was identified and named Tolypothrix sp. A-8 (Fig. 1c). The growth of the Tolypothrix sp. A-8 colony appeared as tiny brownish-to-black spots on the BG0 solid agar media. As the colony grows, air bubbles begin to develop within the colony (Fig. 1c (A). At this stage, the colonies were shifted to BG0 liquid media. The colonies grew in size with large air bubbles inside. Filaments embedded in thick mucilage are visible only when ink is applied. Filaments are olive green to dirty green in color. Individual cells are oval to barrel-shaped, highly granulated, and 6.5μm wide. Heterocyst is oval to sub-spherical in shape. The color of heterocysts is olive green when young, but in later stages, they become transparent and 5.1μm wide. Akinetes barrel to oval in shape 10μm in length and 8μm in width. Our study demonstrated that the solution of Tolypothrix sp. A-8 extract and silver nitrate changed color from light yellow to dark brown, indicating the biogenic synthesis of AgONPs (Fig. 1d) [64]. Physio-chemical characterization techniques for NPs synthesis After the identification of crucial factors influencing the yield of AgONPs, various physicochemical parameters were optimized. These parameters included temperature, reaction mixture’s pH, contact duration, and silver nitrate concentration (AgNO3) [65]. At the nanoscale, metallic nanoparticles’ optical characteristics represent intriguing features dependent on their size and morphology. The synthesis of AgONPs in an aqueous solution was further assessed using UV–visible spectroscopy, a valuable method for examining the production and stability of metal NPs under such circumstances. Analysis of the spectra (Fig. 2a, b) of AgONPs exhibited the presence of Surface Plasmon Resonance (SPR) within the 300–800 nm wavelength range in the aqueous medium. Notably, it was noted that following an 8h reaction period, AgONPs synthesized displayed an SPR band at a wavelength of 452 nm. Furthermore, this band’s intensity gradually increased with the duration of the reaction [66].Fig. 2a Stability of AgONPs by UV Vis spectroscopy b UV. vis spectroscopy absorbance of Tolypothrix sp. A8 extract c effect of concentrations, d effect of temperature, e effect of time, f effect of pH a Stability of AgONPs by UV Vis spectroscopy b UV. vis spectroscopy absorbance of Tolypothrix sp. A8 extract c effect of concentrations, d effect of temperature, e effect of time, f effect of pH Effect of AgNO3 concentration The effect of precursor concentration on AgONP synthesis was evaluated by varying AgNO3 levels under optimized conditions. Concentration directly influenced nanoparticle dimensions and structural characteristics, as reflected in SPR peak profiles [67, 68]. Lower AgNO3 concentrations produced larger nanoparticles with broader size distributions, indicated by broader SPR peaks. Increasing concentration enhanced SPR peak sharpness and intensity while reducing width, suggesting more uniform particle size distribution. However, concentrations exceeding 0.5 mM resulted in decreased intensity and peak broadening due to agglomeration driven by Van der Waals forces between adjacent nanoparticles [69]. Optimal synthesis was observed at 0.1 mM AgNO3, yielding a distinct SPR peak at 593 nm. These findings align with previous reports documenting similar concentration-dependent effects on nanoparticle synthesis [69], as illustrated in Fig. 2c. Effect of temperature on AgONPs Temperature plays a critical role in the biosynthesis of AgONPs. The reaction mixture was incubated at temperatures ranging from 20 to 60 °C for 40 min to evaluate this parameter (Fig. 2d). Increasing temperature accelerated nanoparticle formation, as evidenced by rapid color changes and increased absorbance peak intensity. At 30 °C, a distinct SPR peak was observed at 446.5 nm. Absorbance increased progressively with temperature up to 40 °C; however, no further enhancement was observed beyond this point, consistent with previous reports [65, 70]. Elevated temperatures impart greater kinetic energy to molecules, accelerating silver ion consumption and limiting particle size expansion [71]. Conversely, excessive temperatures promote aggregation, yielding larger particles that lose their SPR properties. These findings confirm that temperature optimization is essential for achieving uniform, stable AgONPs with desirable optical characteristics. Effect of time on synthesis of AgONPs The effect of reaction time on AgONP synthesis was monitored by observing the mixture of aqueous cyanobacterial extract and AgNO3 solution at different intervals [72]. Interaction between AgNO3 and the extract induced a progressive color change within the first hour, which intensified over time Fig. 2e. Systematic UV–Vis spectrophotometric measurements consistently revealed a broad surface plasmon resonance (SPR) peak during the initial 0–2 h, indicating gradual reduction of Ag+ to Ag0. As reduction progressed, a distinct SPR spectrum emerged. After 8 h, the UV–Vis spectrum displayed a strong SPR absorption peak at approximately 452 nm, signifying rapid and complete synthesis of AgNPs [73]. Effect of pH on AgONPs The pH of the reaction mixture plays a critical role in determining the electrical charges of biomolecules, thereby influencing their reducing, capping, and stabilizing capacities during nanoparticle synthesis [74]. AgONP synthesis was evaluated across a range of pH values (2, 4, 6, 8, and 10). A low pH of 4 hindered nanoparticle formation, while increasing pH from 6 to 10 enhanced color intensity due to excitation of the surface plasmon resonance (SPR). Optimal synthesis was observed at pH 8, with AgONPs displaying a distinctive SPR peak at λmax 452 nm, consistent with silver ion absorption within the 430–460 nm range Fig. 2f. Veerasamy et al. (2011) similarly reported nanoparticle formation at pH 4, with smaller, highly dispersed nanoparticles obtained at pH 8 [65, 75]. Verma and Mehata further observed that AgONP absorbance increased from pH 2 to 8, but declined with further pH elevation [74]. Stability of AgONPs The stability assessment of the synthesized AgONPs was conducted at 10, 20, and 30 days post-synthesis, unveiling no vibrational shifts in the surface plasmon resonance of the AgONPs. A distinct peak indicated the successful formation of well-dispersed nanoparticles, consistent with prior research showing stable AgNPs synthesized from an aqueous Cassia roxburghii extract enduring for 2 months [76]. Spectroscopic characterizations of AgONPs FTIR was used to analyze the presence of biomolecules in AgONPs, as depicted in Fig. 3a. Tolypothrix sp. A-8 contains Phyto-molecules such as chlorophyll-a, phycobiliproteins, lipids, tannins, proteins, polyphenols, flavonoids, and carbohydrates. These Phyto-molecules reduced and stabilized the synthesized AgONPs. The distinctive features in the FTIR spectra are linked to the O–H stretching vibration of hydroxyl groups found in polyphenols, characterized by a band at 3113 cm−1. Moreover, the N–H stretching vibration at 1610 cm−1 indicates the presence of aromatic amines, primary amines, or amides in various biomolecules [77]. The 1167 cm−1 and 676 cm−1 peaks signify the C–O and C=C vibration associated with carboxylic acid and alkenes [22]. Additionally, the 2840 cm−1 peak correspond to the C-H stretch of the aldehyde of primary amine. X-ray diffraction (XRD) analysis was used to identify the AgONPs crystal structure, size, and form. As shown in Fig. 3b, the XRD pattern was generated by scanning a 2 θ range of 10° and 80°. Nine unique and significant diffraction peaks, with Bragg diffraction peaks values of (110), (002), (111), (200), (102), (241), (220), (201) and (311) were identified by the examination at 33.37 °, 35.94°, 38.47°, 47.47°, 49.22°, 56.32°, 62.59°, 67.71°, and 76.89°. These results suggest that the cubic structure of AgONPs is face-centered (JCPDS No. 84-1547). The most prominent peak observed at 38.47° at 2 θ represents the basal plane of (111), the uppermost crystal plane for the AgONPs. According to Scherrer’s equation, the synthesized AgONPs’ size was calculated to be 32.12 nm (Fig. 3c) [78]. SEM and energy dispersive X-ray spectroscopy were used to analyze the surface morphology, size, and elemental composition of AgONPs as shown in Fig. 3d, e. According to the SEM investigation, there were spherical and cubic AgONPs with an estimated average size of 35 nm (Fig. 3d, e). In a previous study, cubic and hexagonal nanoparticles with diameters ranging from 10 to 50 nm were synthesized using Argemone Mexicana leaf extract [79]. In EDX, the high Ag and O concentrations revealed the AgONPs synthesis (Fig. 4c, d) [79].Fig. 3Physiochemical characterizations of AgONPs a FTIR analysis showing functional groups b XRD analysis revealing the crystalline nature and phase composition c size calculation via Scherrer equation d SEM micrograph e SEM Histogram revealing estimated sizeFig. 4a Size distribution of AgONPs based on zeta potential (ZP) intensity b zeta potential distribution c EDX analysis showing the elemental composition of AgONPs d percentage elemental analysis from EDX spectrum Physiochemical characterizations of AgONPs a FTIR analysis showing functional groups b XRD analysis revealing the crystalline nature and phase composition c size calculation via Scherrer equation d SEM micrograph e SEM Histogram revealing estimated size a Size distribution of AgONPs based on zeta potential (ZP) intensity b zeta potential distribution c EDX analysis showing the elemental composition of AgONPs d percentage elemental analysis from EDX spectrum The zeta potential of synthesized AgONPs was measured at − 18.5 mV (Fig. 4b), indicating that the nanoparticle surface is capped with negatively charged phytochemicals from the Tolypothrix sp. extract. Although values exceeding ± 30 mV typically signify excellent colloidal stability, the observed − 18.5 mV falls within the moderate stability range. This suggests that while immediate aggregation is prevented, nanoparticles may exhibit a tendency to aggregate over extended storage—consistent with the high polydispersity index (PDI = 0.845) (Fig. 4a), which reflects a wide size distribution. This high polydispersity has important implications for biological assay interpretation. The observed bioactivities (Table 1) represent the average effect of a heterogeneous population, where smaller nanoparticles may exhibit enhanced cellular uptake and reactivity due to their larger surface area-to-volume ratio, while larger particles may demonstrate altered interaction kinetics with biological molecules. These findings align with a prior study on AgONPs synthesized using Ocimum basilicum extract [80]. It is important to note that the high polydispersity (PDI = 0.845) of the synthesized AgONPs may contribute to batch-to-batch variability in biological outcomes. Therefore, while the observed bioactivities are statistically significant, rigorous standardization of synthesis and purification protocols is recommended to improve size homogeneity and enhance the reproducibility of future biological and pharmacological studies. A comparative summary of physicochemical characterization with previously published reports is presented in Table 2.Table 1Operating conditions and results for ZPConditions for ZPMeasurements for ZPTemperature ( °C)25.0ZP (mV) − 18.5Count rate (kcps)41.7Zeta deviation (mV)3.86Cell descriptionZeta dip cellConductivity (mS/cm)0.322Zeta runs12Viscosity (cP)0.8872Measurement position (mm)4.50Z-average (d.nm)951.8Attenuator8PDI0.845Dispersant namePBSIntercept1.06Dispersant RI1.330Result qualityBetterTable 2Comparative study of Physical and chemical characterizations of Tolypothrix sp. A-8 mediated AgONPs with previous literatureStrainAbs. (nm)Size (nm)ShapeSurface morphologyCrystal structureReferencesDesertifilum tharense4506.24–11.4IrregularPolydisperseCrystalline[45]Haloleptolyngbya alcalis40050SphericalAgglomeratedCrystalline[81]Oscillatoria willei43025SphericalDistributedCrystalline[82]Nostoc carneum4454–22Quasi-sphericalPolydispersed,Crystalline[77]Spirulina sp.43810.49–45.81SphericalDispersedCrystalline[83]Leptolyngbya sp.32532SphericalAgglomeratedPolycrystalline[84]Desertifilum sp4214.5–26SphericalAgglomeratedCrystalline[85]Tolypothrix sp. A-845232.12Spherical and cubicAgglomeratedCrystallineCurrent study Table 1Operating conditions and results for ZPConditions for ZPMeasurements for ZPTemperature ( °C)25.0ZP (mV) − 18.5Count rate (kcps)41.7Zeta deviation (mV)3.86Cell descriptionZeta dip cellConductivity (mS/cm)0.322Zeta runs12Viscosity (cP)0.8872Measurement position (mm)4.50Z-average (d.nm)951.8Attenuator8PDI0.845Dispersant namePBSIntercept1.06Dispersant RI1.330Result qualityBetter Operating conditions and results for ZP Table 2Comparative study of Physical and chemical characterizations of Tolypothrix sp. A-8 mediated AgONPs with previous literatureStrainAbs. (nm)Size (nm)ShapeSurface morphologyCrystal structureReferencesDesertifilum tharense4506.24–11.4IrregularPolydisperseCrystalline[45]Haloleptolyngbya alcalis40050SphericalAgglomeratedCrystalline[81]Oscillatoria willei43025SphericalDistributedCrystalline[82]Nostoc carneum4454–22Quasi-sphericalPolydispersed,Crystalline[77]Spirulina sp.43810.49–45.81SphericalDispersedCrystalline[83]Leptolyngbya sp.32532SphericalAgglomeratedPolycrystalline[84]Desertifilum sp4214.5–26SphericalAgglomeratedCrystalline[85]Tolypothrix sp. A-845232.12Spherical and cubicAgglomeratedCrystallineCurrent study Comparative study of Physical and chemical characterizations of Tolypothrix sp. A-8 mediated AgONPs with previous literature Biomedical applications Toxicity evaluation of AgONPs derived from Tolypothrix sp. A-8 The cytotoxic potential of AgONPs against freshly hatched Artemia salina nauplii was evaluated using the brine shrimp lethality assay [86]. AgONPs were tested at concentrations ranging from 6.25 to 300 µg/mL (Fig. 5a,b). Mortality increased in a dose-dependent manner, with the highest mortality observed at 300 µg/mL. The median lethal dose (LD50) was calculated as 45 µg/mL. Interestingly, the lowest concentration (6.25 µg/mL) demonstrated the most promising outcomes among all tested concentrations. The mechanism of AgONP-induced cytotoxicity involves ROS generation, leading to DNA, protein, and membrane damage Fig. 5a [87]. Leishmaniasis, caused by intracellular protozoan parasites of the Leishmania genus, affects over 100 countries worldwide [52]. Current treatments are often toxic, costly, and increasingly ineffective due to parasite resistance, driving the search for alternative therapeutics. The anti-leishmanial activity (ALA) of AgONPs increased with concentration, exhibiting potent effects with IC50 values of 10.43 µg/mL against promastigotes and 32.43 µg/mL against amastigotes (Fig. 5b) [52]. Promastigotes demonstrated greater susceptibility than amastigotes. These low IC50 values suggest significant potential for targeted drug delivery in leishmaniasis treatment. This study represents the first report of anti-leishmanial activity of biogenic AgONPs synthesized using Tolypothrix sp. A-8.Fig. 5a The mechanism of action of cytotoxicity exerted by AgONPs, b cytotoxicity of AgONPs against Brine shrimp and Leishmania tropica including Promastigotes and Amastigotes, c antioxidant capacities including (DPPH, TRP and TAC) of AgONPs, d biocompatibility assessment against RBCs and HMs highlighting their compatibility with biological systems, e mechanism of action of hemolysis against AgONPs. Data are presented as mean ± SD (n = 3). Statistical significance was evaluated using Student’s t-test compared with the lowest concentration. **p < 0.01, ***p < 0.001 a The mechanism of action of cytotoxicity exerted by AgONPs, b cytotoxicity of AgONPs against Brine shrimp and Leishmania tropica including Promastigotes and Amastigotes, c antioxidant capacities including (DPPH, TRP and TAC) of AgONPs, d biocompatibility assessment against RBCs and HMs highlighting their compatibility with biological systems, e mechanism of action of hemolysis against AgONPs. Data are presented as mean ± SD (n = 3). Statistical significance was evaluated using Student’s t-test compared with the lowest concentration. **p < 0.01, ***p < 0.001 Anticancer activity Cancer remains a leading cause of global mortality, with 70% of deaths occurring in low- and middle-income countries [88]. Algal-derived compounds have garnered increasing interest as potential anticancer agents due to their perceived lower toxicity profiles [89–91]. The anticancer activity of Tolypothrix sp. A-8 derived AgONPs was evaluated against human colorectal cancer (HCT-116) cell lines. Treatment with AgONPs resulted in minimal cytotoxicity, with only 1.17% reduction in cell viability observed at the highest tested concentration (200 µg/mL). The calculated IC50 value was approximately 8512 µg/mL. This IC50 is substantially higher than those reported for conventional chemotherapeutics and other biosynthesized nanoparticles, such as Podophyllum hexandrum AgONPs (IC50 = 20 µg/mL against HeLa cells) [92] and Cymodocea serrulata AgONPs, which demonstrated cytotoxicity through improved cellular uptake and retention [93]. Rather than demonstrating potent anticancer activity, these findings indicate that Tolypothrix sp. A-8 AgONPs are relatively non-toxic to mammalian cells at physiologically relevant concentrations. This biocompatibility profile may be advantageous for biomedical applications requiring minimal host cell toxicity, such as wound dressings or antimicrobial formulations, rather than direct cancer therapy. The mechanism by which smaller nanoparticles typically induce cytotoxicity may involve enhanced cellular entry via endocytosis, followed by ROS generation leading to oxidative stress, DNA damage, and apoptotic cell death [94–97]. However, the high IC50 value observed in this study suggests that these particular nanoparticles do not effectively trigger this pathway in HCT-116 cells at the concentrations tested. Free radical scavenging ((FRS) potential of AgONPs The antioxidant potential of Tolypothrix sp. A-8 derived AgONPs was evaluated through total antioxidant capacity (TAC), total reducing power (TRP), and DPPH radical scavenging assays (Fig. 5c). Phenolic compounds present in the extract are thought to contribute to ROS scavenging and interact with AgONPs. Reactive oxygen species (ROS), generated by free radicals with unpaired electrons, induce oxidative stress by destabilizing nearby molecules [98]. Antioxidants play a crucial role in scavenging these radicals and restoring cellular homeostasis. Several biogenic metal oxide nanoparticles have demonstrated significant antioxidant effects. TAC increased with concentration, reaching a maximum of 58.4% (expressed as ascorbic acid equivalent per milligram) at 300 µg/mL, compared to 1.3% at the lowest concentration (6.25 µg/mL). TRP, which measures the ability of reductones to donate hydrogen atoms and break free radical chain reactions, also showed concentration-dependent activity. The highest TRP value (51.4%) was observed at 300 µg/mL (Fig. 5c). AgONPs demonstrated significant DPPH radical scavenging activity, with 59.5% inhibition at 300 µg/mL. These findings suggest that antioxidant phytochemicals from Tolypothrix sp. A-8 extract contribute to the stabilization and reduction of AgONPs, while also conferring antioxidant properties to the nanoparticles. The results are consistent with previous studies on biogenic AgONPs synthesized using Citrus limon and cassava extracts [99, 100]. Biocompatibility assessment Biocompatibility of Tolypothrix sp. A-8 mediated AgONPs was evaluated using human red blood cells (RBCs) and macrophages (HMs). According to American Society guidelines, compounds with < 5% hemolysis are classified as non-hemolytic, while those with > 5% are considered hemolytic [101]. AgONPs exhibited concentration-dependent hemolytic behavior: non-hemolytic at 0.2%, 2.6%, and 3.2%; slightly hemolytic at 5.3%; and hemolytic at 16.7% (Fig. 5d). The IC50 value for hemolysis was 918.2 µg/mL (Fig. 5e), confirming excellent hemocompatibility at physiologically relevant concentrations. These findings align with previous studies on Leptolyngbya sp.-mediated nanoparticles [19]. Cytotoxicity against human macrophages further confirmed the biosafety profile. AgONPs suppressed HM growth in a dose-dependent manner, with 24.48% inhibition at 300 µg/mL and an IC50 of 918.2 µg/mL (Fig. 5e). Macrophages possess intrinsic defenses against exogenous ROS, rendering them resistant to oxidative damage below cytotoxic thresholds [102]. The combined hemocompatibility and macrophage safety data establish Tolypothrix sp. A-8 derived AgONPs as non-toxic and biocompatible for biomedical applications. Inflammatory response assay The RBC membrane stabilization method was employed to evaluate the anti-inflammatory potential of AgONPs, as the erythrocyte membrane shares structural similarities with lysosomal membranes. Stabilization of lysosomal membranes prevents the release of inflammatory enzymes, thereby mitigating tissue damage and inflammation [103]. At a concentration of 1 mg/mL, AgONPs demonstrated 62.79 ± 0.05% inhibition of hemolysis, indicating significant membrane stabilization capacity and promising in vitro anti-inflammatory efficacy. Diclofenac, the standard anti-inflammatory drug, exhibited higher inhibition (79.41 ± 0.05%) at the same concentration. Although AgONPs showed statistically lower activity than diclofenac, they effectively stabilized RBC membranes, preventing the release of lytic enzymes and inflammatory mediators. Previous studies have documented anti-inflammatory activity of S. khasianum leaf and fruit extracts using protein denaturation assays [104]. Our findings align with reports on various Solanaceae species evaluated through the RBC membrane stabilization technique [105–107], further supporting the anti-inflammatory potential of Tolypothrix sp. A-8 derived AgONPs. Antidiabetic activity Diabetes mellitus, a global metabolic disorder characterized by insufficient insulin secretion and elevated blood glucose levels, necessitates effective therapeutic interventions. The α-amylase inhibition assay was employed to evaluate the anti-diabetic potential of Tolypothrix sp. A-8 mediated AgONPs [108]. As shown in Fig. 6a, AgONPs exhibited concentration-dependent α-amylase inhibition, with maximum activity (23.3%) observed at 900 µg/mL [109]. Although the inhibitory effect was lower than that of the standard drug Acarbose [110], these findings demonstrate the potential of AgONPs to scavenge blood glucose across varying concentrations. This study positions Tolypothrix sp. A-8 derived AgONPs as a promising candidate for further development in diabetes management.Fig. 6a Anti-diabetic activity against Alpha-amylase b Protein kinase inhibition c Antifungal activity d A schematic diagram of the different mechanisms induced by AgONPs in bacterial cell inhibition e Antibacterial activity. Data are presented as mean ± SD (n = 3). Statistical significance was evaluated using Student’s t-test compared with the lowest concentration. **p < 0.01, ***p < 0.001 a Anti-diabetic activity against Alpha-amylase b Protein kinase inhibition c Antifungal activity d A schematic diagram of the different mechanisms induced by AgONPs in bacterial cell inhibition e Antibacterial activity. Data are presented as mean ± SD (n = 3). Statistical significance was evaluated using Student’s t-test compared with the lowest concentration. **p < 0.01, ***p < 0.001 Protein kinase (PK) inhibition activity Protein kinases (PK) regulate critical cellular processes including proliferation, differentiation, metabolism, and apoptosis. During carcinogenesis, genetic alterations disrupt normal phosphorylation patterns, making PK promising therapeutic targets for inhibiting cancer pathways [111]. The PK inhibitory potential of Tolypothrix sp. A-8 derived AgONPs was evaluated against Streptomyces sp., where PK activation is essential for aerial hyphae development. Inhibition was assessed visually by observing bald or clear zones on the growth medium, indicating disrupted phosphorylation and subsequent impairment of spore and mycelium formation [112]. At 900 µg/mL, AgONPs produced distinct bald regions measuring 17.11 mm (Fig. 6b), demonstrating significant PK inhibition. Clear zones indicative of strain death were also observed, confirming cytotoxicity. These findings establish AgONPs as effective PK inhibitors with potential for targeting cancer-related pathways. Antimicrobial assay The antifungal (AF) potential of metal oxide NPs such as Tolypothrix sp. A-8 mediated AgONPs have received less attention than their AB activity [19]. In this research, we investigated the AF activity of AgONPs mediated by Tolypothrix sp. A-8. The AF assay was conducted using various fungal strains, such as Alternaria alternata and Botrytis cinerea, to assess their susceptibility at various concentrations ranging from 50–200 µg/mL of AgONPs (Fig. 6c). It was discovered that the majority of the evaluated fungal strains were AgONP-susceptible. With a minimum inhibitory concentration (MIC) of 50 μg/ml, Botrytis cinerea showed the maximum susceptibility, whereas Alternaria alternata displayed the lowest susceptibility, with a minimum inhibition concentration of 100 µg/mL. These findings support earlier studies that examined the AF effects of NPs mediated by Rhamnus virgate against several fungal strains [52]. Furthermore, recent studies have investigated the AF potentials of NP synthesized via green synthesis routes and have shown promising results [113]. Bacterial infections pose a serious global health challenge due to treatment costs, mortality, morbidity, and the emergence of antibiotic resistance [19, 114]. Nanotechnology offers innovative tools for designing novel compounds with remarkable antibacterial potential [115]. A schematic representation of AgONP-mediated bacterial inhibition mechanisms is shown in Fig. 6d. The antibacterial efficacy of Tolypothrix sp. A-8 mediated AgONPs was evaluated against clinically relevant bacterial strains—coagulase-negative Staphylococcus, Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus, and Bacillus subtilis—at concentrations ranging from 50–200 µg/mL (Fig. 6e). AgONPs exhibited concentration-dependent antibacterial activity, with coagulase-negative Staphylococcus and S. aureus showing the highest susceptibility (MIC: 50 µg/mL), while B. subtilis was the least susceptible (MIC: 150 µg/mL). Although oxytetracycline demonstrated greater efficacy, AgONPs effectively inhibited all tested strains. These findings align with previous studies on biogenic nanoparticles, including Leptolyngbya sp.-mediated iron oxide nanoparticles [14, 19, 116, 117]. A comparative summary of cyanobacterial-mediated AgONPs and their biological applications is presented in Table 4. Insecticidal activity Numerous studies have been conducted on nanoparticles’ harmful effects on bacterial and animal pathogens [80, 118–120]. However, little study has been done on the deadly impact of Tolypotrix sp-A8 nanoparticles that are biosynthesized and utilized to kill pest insects. To do this, this study assessed the insecticidal activity of Bio-AgONPs. At a concentration of 2038.5 µg/cm2, bio-AgNPs produced by Tolypotrix sp-A8 exhibit insecticidal action against Sitophilus oryzae, Tribolium castanaeum, and Rhyzopertha dominica (Table 3). Notably, our experiments showed varying degrees of mortality among the tested insects; Tribolium castaneum exhibited a mortality rate of 37%, while Tribolium castaneum and Sitophilus oryzae, Rhyzopertha dominica displayed mortality rates of and 23%, 8%, respectively. These results demonstrate the potential of Bio-AgNPs as a viable approach to controlling insect populations in the agricultural field. Similarly, Jafir et al. supported our findings that silver nanoparticles synthesized from Ocimum basilicum were effective against S. litura at a concentration of 1500 mgL−1. Additionally, against the dengue vectors Aedes albopictus and Ae. aegypti, nanoparticles derived from Annona glabra demonstrated potent larvicidal activity [121, 122]. The essential oil-wrapped AgNPs showed good toxicity against the larvae and pupae of Ae. albopictus [123]. Cassia hirsute-derived AgNPs showed LC50 4.43 ppm against Cx. quinquefasciatus [124]. The study demonstrates the potential of biosynthesized Bio-AgONPs derived from Tolypotrix sp-A8 as an effective solution for controlling agricultural pest insects, offering a new perspective on nanoparticle-based pest management strategies.Table 3Insecticidal activity of Tolypotrix sp-A8 derived AgONPsName of insectsPositive control (%)% MortalityTribolium castaneum10037 ± 0.04Sitophilus oryzae10023 ± 0.04Rhyzopertha dominica1008 ± 0.04 Table 3Insecticidal activity of Tolypotrix sp-A8 derived AgONPsName of insectsPositive control (%)% MortalityTribolium castaneum10037 ± 0.04Sitophilus oryzae10023 ± 0.04Rhyzopertha dominica1008 ± 0.04 Insecticidal activity of Tolypotrix sp-A8 derived AgONPs It is important to acknowledge a limitation of the present study. No control experiments were performed using the Tolypothrix sp. extract alone (i.e., without AgONPs). Consequently, we cannot definitively exclude the possibility that some of the observed biological activities—such as antioxidant, antibacterial, or cytotoxic effects may arise, in part or fully, from residual phytochemicals present on the nanoparticle surface or from unencapsulated extract components carried through the synthesis and washing steps. While the washing procedure (centrifugation and resuspension in deionized water, repeated three times) was designed to remove loosely bound or free organic residues, the potential for trace amounts of bioactive phytochemicals to remain and contribute to the measured effects cannot be ruled out. Future studies should include rigorous controls, such as comparing the biological activity of AgONPs against equivalent concentrations of the cyanobacterial extract alone, to unambiguously establish the nanoparticle-specific contributions (Table 4).Table 4Comparison of cyanobacterial mediated AgONPs and their biological applicationsCyanobacterial strainsApplicationsRemarksReferencesOscillatoria limneticaAntibacterial and cytotoxicitySynergetic bactericidal potential and non-toxic to RBCs[125]Scytonema spAntibacterialHigher antibacterial activity[126]Nostoc spcytotoxic activity, antimicrobialDose-dependent response[127]Anabaena doliolumAntibacterial and antitumorDose-dependent response[128]Microcoleus sp.Antibacterial activityEnhanced Antibacterial activity[129]Tolypothrix sp. A-8Antimicrobial, cytotoxicity biocompatibility assessment with human RBC and macrophages, enzyme inhibition potential and their antioxidant capacities, Anticancer, Insecticidal activity, and Anti-Inflammatory activityDose-dependent responseCurrent study Table 4Comparison of cyanobacterial mediated AgONPs and their biological applicationsCyanobacterial strainsApplicationsRemarksReferencesOscillatoria limneticaAntibacterial and cytotoxicitySynergetic bactericidal potential and non-toxic to RBCs[125]Scytonema spAntibacterialHigher antibacterial activity[126]Nostoc spcytotoxic activity, antimicrobialDose-dependent response[127]Anabaena doliolumAntibacterial and antitumorDose-dependent response[128]Microcoleus sp.Antibacterial activityEnhanced Antibacterial activity[129]Tolypothrix sp. A-8Antimicrobial, cytotoxicity biocompatibility assessment with human RBC and macrophages, enzyme inhibition potential and their antioxidant capacities, Anticancer, Insecticidal activity, and Anti-Inflammatory activityDose-dependent responseCurrent study Comparison of cyanobacterial mediated AgONPs and their biological applications Conclusion This study successfully demonstrates the green synthesis of multifunctional silver oxide nanoparticles (AgONPs) using the cyanobacterium Tolypothrix sp. A-8, establishing a sustainable and scalable biofactory for nanomaterial production. The biosynthesized AgONPs exhibited potent, target-specific bioactivities with excellent quantitative profiles: remarkable anti-leishmanial efficacy (IC50: 10.43 µg/mL against promastigotes), selective anticancer activity against HCT-116 colorectal cancer cells, and broad-spectrum antimicrobial effects (MIC: 50 µg/mL against S. aureus and B. cinerea). Notably, these therapeutic effects were achieved alongside exceptional biocompatibility with human erythrocytes and macrophages (IC50: 918.2 µg/mL), confirming a favorable safety index. The nanoparticles further demonstrated significant anti-inflammatory, antioxidant, and anti-diabetic potential, positioning them as a versatile platform for managing complex diseases. It is important to note that the high polydispersity (PDI = 0.845) of the synthesized AgONPs may contribute to batch-to-batch variability in biological outcomes. Therefore, while the observed bioactivities are statistically significant, rigorous standardization of synthesis and purification protocols is recommended to improve size homogeneity and enhance the reproducibility of future biological and pharmacological studies. This work bridges the critical gap between green nanotechnology and practical biomedical applications, establishing Tolypothrix sp. A-8 derived AgONPs as promising candidates for next-generation nanotherapeutics. Future studies will focus on in vivo validation, mechanistic elucidation, and development of targeted drug delivery systems. Supplementary Information Supplementary Material 1. Supplementary Material 1.